Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent need for a reevaluation and restructuring.
Some pharma companies are facing immense pressure to ramp up production to meet soaring demand for anti-obesity drugs while maintaining drug efficacy and safety standards. This dual pressure brings q… [+5672 chars]
